Pharmacology

Invokamet For Treatment Of Type 2 Diabetes Approved

The U.S. Food and Drug Administration has approved INVOKAMET™, a fixed-dose therapy combining canagliflozin and metformin hydrochloride in a single tablet, for the treatment of adults with type 2 diabetes. INVOKAMET provides the clinical attributes of INVO ...

Article - News Staff - Aug 10 2014 - 5:00pm

Doctor Shopping: 21 Percent Of Adult Orthopedic Patients Find New Doctors For Narcotic Prescriptions

"Doctor shopping" is the term for obtaining narcotic prescriptions by seeking out multiple providers that has led to measurable increases in drug use among postoperative trauma patients. A new paper links doctor shopping to higher narcotic use a ...

Article - News Staff - Aug 11 2014 - 12:28pm

Chloroquine: Malaria Medicine Inhibits Tumor Growth, Metastases

...

Article - News Staff - Aug 11 2014 - 11:00pm

Digoxin Deaths Are Why We Shouldn't Trust Medicine Just Because It's Been Around Forever

One of the greatest and most dangerous naturalistic fallacies is that if our ancestors used something, it must be as good or even better than modern science. In An Account of the Foxglove and Some of its Medical Uses, published in 1785, Sir William Wither ...

Article - News Staff - Aug 11 2014 - 8:40pm

Vitamin D Deficiency May Reduce Successful IVF For Women

Women with a vitamin D deficiency were nearly half as likely to conceive through in vitro fertilization (IVF) as women who had sufficient levels of the vitamin, according to a new study in the Journal of Clinical Endocrinology&Metabolism. Long known f ...

Article - News Staff - Aug 14 2014 - 9:30pm

Carbon Monoxide May Prevent Arrhythmia After Heart Attack

A new study has found that carbon monoxide could be used to protect against life-threatening arrhythmias after a heart attack. Restoring blood flow to the heart following a heart attack can leave patients with ventricular fibrillation, a dangerous heart rh ...

Article - News Staff - Aug 16 2014 - 8:30am

No Proof Of Added Benefit For Perampanel In Epilepsy

The drug perampanel (trade name Fycompa) has been approved since July of 2012 as an adjunctive ("add-on") therapy for adults and children aged 12 years and older with seizures- colloquially also known as epileptic fits. In a new early benefit as ...

Article - News Staff - Aug 19 2014 - 6:30pm

Indication Of Considerable Added Benefit Using Ruxolitinib For Myelofibrosis

Ruxolitinib (trade name: Jakavi) has been approved since August 2012 for the treatment of adults with myelofibrosis. Myelofibrosis is a rare disease of the bone marrow, in which the bone marrow is replaced by connective tissue. As a consequence of this so ...

Article - News Staff - Aug 20 2014 - 7:30am

For E. Coli Outbreaks, Cinnamon Spice Makes Everything Nice

By Allison Jarrell, Inside Science For centuries, cinnamon has been used to enhance the flavor of foods, but new research shows that the spice could also help make foods safer. According to a study by Meijun Zhu and Lina Sheng, food safety scientists at W ...

Article - Inside Science - Aug 22 2014 - 12:44pm

How Science Is Using The Genetics Of Disease To Make Drugs Better

By Mark Lawler, Queen's University Belfast Personalized medicine is the ability to tailor therapy to an individual patient so that, as it’s often put, the right treatment is given to the right patient at the right time. But just how personal is it? W ...

Article - The Conversation - Aug 21 2014 - 11:30am